CIK 0001514183
- Non-accelerated filer
- Smaller reporting company
Silo Pharma, Inc.
Sign in to watch- Ticker
- SILO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 462137136
- Phone
- +1 718-400-9031
- Business address
- 677 N. WASHINGTON BLVD, SARASOTA, FL, 34236
- Former names
- Uppercut Brands, Inc., Point Capital, Inc., Gold Swap Inc
- 4 Open-market buy CEO and President bought 2,900 shares at an average $1.46 ($4,235)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $2.13 ($2,126)
- 4 Open-market buy CEO and President bought 3,000 shares at an average $2.07 ($6,204)
- 4 Open-market buy CEO and President bought 330 shares at an average $2.70 ($890)
- 4 Open-market buy CEO and President bought 750 shares at an average $3.10 ($2,328)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO, CFO and President bought 13,080 shares at $0.11 ($1,500)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 22,500 shares at an average $0.14 ($3,187)
- 4/A Grant or award CEO, CFO and President acquired 7,630,949 shares (grant or award)
- 4 Open-market buy CEO, CFO and President bought 58,114 shares at an average $0.00 ($281)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 7,630,949 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 3 · 58 filings